Success Metrics

Clinical Success Rate
87.5%

Based on 7 completed trials

Completion Rate
88%(7/8)
Active Trials
4(29%)
Results Posted
57%(4 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
12
86%
Ph phase_1
1
7%
Ph early_phase_1
1
7%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
1(7.1%)
N/ANon-phased studies
12(85.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

4

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(7)
Terminated(1)

Detailed Status

Completed7
Recruiting4
Enrolling by invitation1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
4
Success Rate
87.5%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (7.1%)
Phase 11 (7.1%)
N/A12 (85.7%)

Trials by Status

recruiting429%
enrolling_by_invitation17%
not_yet_recruiting17%
terminated17%
completed750%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14